how do you microdose semaglutide Microdosing GLP-1s: A Doctor's Guide to Gentle, Effective Metabolic Reset: Shamsah Amersi, MD: OB-GYNs What Is Microdosing Semaglutide? |

Sleep and depression are considered to be closely related

Novo Nordisk is already running two trials of semaglutide in patients with early Alzheimers disease Evoke and Evoke+ with data expected in 2025

The compound is currently FDA-approved under two brand names: Mounjaro for the treatment of type 2 diabetes Zepbound for chronic weight management in obese or overweight individuals Clinical trials have highlighted Tirzepatides superior weight-loss effects compared to other GLP-1 drugs

The study, International coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches, was published on August 16, 2024 in the Lancet

Rapid weight loss with any peptide tends to cause some muscle loss alongside fat loss